A Prospective, Multicenter, Prospective, Non-intervention, Controlled Trial of MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer in Realistic Medical Practice

Peking University1 site in 1 country484 target enrollmentNovember 1, 2017

ConditionsMulti-disciplinary Treatment

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Multi-disciplinary Treatment
Sponsor: Peking University
Enrollment: 484
Locations: 1
Primary Endpoint: overall survival
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.

Registry

clinicaltrials.gov

Start Date

November 1, 2017

End Date

June 2020

Last Updated

8 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Peking University

Responsible Party

Principal Investigator

Shen Lin

Head of department of Gastroentestinal oncology

Peking University

Eligibility Criteria

Inclusion Criteria

•Histopathological diagnosis of recurrent / metastatic gastric or colorectal cancer.
•Participate in formal MDT discussions at the Research Center.
•MDT decision-making at least two subjects involved in treatment.
•Patient informed consent and signed written consent.

Exclusion Criteria

•Early or locally advanced gastric cancer or colorectal cancer.
•Accept informal MDT discussions.
•MDT decisions recommend only a single subject for treatment of patients.
•MDT decisions recommend only palliative patients.

Outcomes

Primary Outcomes

overall survival

Time Frame: From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months